CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study

Author: Miroševic Skvrce Nikica   Božina Nada   Zibar Lada   Barišic Ivan   Pejnovic Lana   Macolic Šarinic Viola  

Publisher: Future Medicine

ISSN: 1462-2416

Source: Pharmacogenomics, Vol.14, Iss.12, 2013-09, pp. : 1419-1431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content